BEIJING, Jan. 4, 2023
/PRNewswire/ -- Waterdrop and Jemincare recently reached a
cooperation, according to which both sides will jointly launch the
"Digital Service Platform for CKD Patients". Featuring both online
and offline service modules ranging from follow-up visits and
consultation with doctors to interpretation of data reports and
popularization of disease knowledge, the platform is expected to
offer patients efficient, convenient, and integrated chronic
disease management services, and enhance their experience even
without visiting hospitals.
Jemincare is committed to delivering CKD patients with a better
experience in drug use, diagnosis, and treatment by offering
services outside hospitals throughout the course of the disease.
Boasting a series of proven tools devised to improve patient
management services, Waterdrop Patient Platform, built on a
patient-centric approach, can provide patients with services in the
whole disease course outside hospitals. The bilateral cooperation
is of positive significance in helping CKD patients solve problems
associated with diagnosis, drug use, and daily care during the long
cycle of treatment.
According to Yao Hu, co-founder
of Waterdrop and General Manager of Waterdrop's Pharmaceutical
Innovation Business Unit, Waterdrop Patient Platform enjoys a solid
foundation in offering patient services across the whole disease
course outside hospitals and has put in place a multi-dimensional
operation system that provides patients with one-on-one Q&A
services related to reporting interpretation, drug use, disease
knowledge explanation, nutrition & lifestyle guidance, and
psychological support. As of September
2022, the platform had served 3 million patients with severe
diseases and set up nearly 1,600 communities that covered patients
of 12 common serious diseases and rare diseases. "Centering on
patient needs, Waterdrop Patient Platform will further optimize
service processes to bring more comprehensive, professional, and
considerate services to patients. Also, empowered by digital
technologies, the platform can help pharmaceutical partners boost
quality and efficiency."
About Waterdrop Inc.
Waterdrop Inc. (NYSE: WDH) is a leading technology platform
dedicated to insurance and healthcare service with a positive
social impact. Founded in 2016, with the comprehensive coverage of
Waterdrop Insurance Marketplace and Waterdrop Medical Crowdfunding,
Waterdrop aims to bring insurance and healthcare service to
billions through technology. For more information, please visit
www.waterdrop-inc.com.
Safe Harbor Statement
This press release contains statements that may constitute
"forward-looking" statements pursuant to the "safe harbor"
provisions of the U.S. Private Securities Litigation Reform Act of
1995. These forward-looking statements can be identified by
terminology such as "will," "expects," "anticipates," "aims,"
"future," "intends," "plans," "believes," "estimates," "likely to,"
and similar statements. Statements that are not historical facts,
including statements about Waterdrop's beliefs, plans, and
expectations, are forward-looking statements. Forward-looking
statements involve inherent risks and uncertainties. Further
information regarding these and other risks is included in
Waterdrop's filings with the SEC. All information provided in this
press release is as of the date of this press release, and
Waterdrop does not undertake any obligation to update any
forward-looking statement, except as required under applicable
law.
View original
content:https://www.prnewswire.com/news-releases/waterdrop-and-jemincare-collaborate-on-the-digital-service-platform-for-ckd-patients-301713005.html
SOURCE Waterdrop Inc.
